# Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study

Study · id `cardio:ct-nct01962545` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01962545](<https://clinicaltrials.gov/study/NCT01962545>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01962545

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 690 participants.

## Technical summary

Registry record NCT01962545. Randomized; no masking; primary purpose treatment. Start 2013-11-05 (actual); primary completion 2017-05-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 690 participants (enrolled count; ClinicalTrials.gov record NCT01962545, source copy `cardio:ctgov-nct01962545-2018-06-11`, retrieved 2026-10-26)
- Started: 2013-11-05 (actual) (ClinicalTrials.gov record NCT01962545, source copy `cardio:ctgov-nct01962545-2018-06-11`, retrieved 2026-10-26)
- Primary completion: 2017-05-18 (actual) (ClinicalTrials.gov record NCT01962545, source copy `cardio:ctgov-nct01962545-2018-06-11`, retrieved 2026-10-26)
- Completion: 2018-05-18 (actual) (ClinicalTrials.gov record NCT01962545, source copy `cardio:ctgov-nct01962545-2018-06-11`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01962545, source copy `cardio:ctgov-nct01962545-2018-06-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01962545-2018-06-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study
- Acronym: OAC-ALONE
- Condition: Atrial Fibrillation
- Condition: Coronary Artery Disease
- Intervention (Drug): OAC alone
- Lead sponsor: Satoshi Shizuta
- Lead sponsor class: OTHER
- Collaborator: Research Institute for Production Development
- Collaborator class: UNKNOWN
- Collaborator: Daiichi Sankyo Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Daiichi Sankyo Co., Ltd. (`cardio:org-daiichi-sankyo-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation (`cardio:pubmed-30586700`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d3e3d76e93eeedff9fc5ba37a9bed089be67e5e2a9391d9b61ac2a7dccf264a4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
